查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1923850

鍺-68市場按應用程式、產品類型、最終用戶和通路分類－2026-2032年全球預測

Germanium 68 Market by Application, Product Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年鍺-68 市值將達到 4.4261 億美元，到 2026 年將成長至 4.9387 億美元，到 2032 年將達到 9.3794 億美元，複合年成長率為 11.32%。

關鍵市場統計數據
基準年 2025 4.4261億美元
預計年份：2026年 4.9387億美元
預測年份 2032 9.3794億美元
複合年成長率 (%) 11.32%

全面介紹鍺-68在臨床影像、放射性藥物工作流程和研究基礎設施中的策略作用

鍺-68在診斷影像、放射性藥物生產和研究應用中發揮著至關重要的作用，它是鎵-68生產的母體放射性核素，也是校準和測試流程中的密封源。此同位素的重要性體現在其崩壞特性以及與發生器系統的兼容性上，這些系統能夠現場生產短壽命正電子發射體（PET），從而有助於在臨床和科研環境中及時獲得放射性示踪劑。 PET設備的科技進步，以及對標靶診斷日益成長的需求，使得了解鍺-68的運作、監管和供應鏈等各個方面對於醫療保健、工業和學術界的相關人員至關重要。

成像技術創新、在局部示蹤劑生產和供應鏈現代化將如何重塑鍺-68的取得和使用

影像技術的創新、放射性藥物研發管線的不斷發展以及對增強區域供應韌性的日益重視，正在推動鍺-68領域發生變革性變化。 PET成像硬體和軟體的進步正在拓展鎵-68衍生放射性示蹤劑的臨床效用，從而增加了對可靠的發生器系統和密封放射源的需求。同時，模組化和照護現場化學平台的出現正在改變醫療機構的現場生產方式，縮短示蹤劑的前置作業時間，並實現更靈活的臨床排期。

評估2025年美國關稅調整及其對鍺-68相關人員業務營運、採購和供應連續性的影響

透過關稅調整實施的政策措施會對放射性核種供應鏈的採購、定價和營運規劃產生連鎖反應。 2025年美國關稅調整將為依賴進口發生器組件和密封源材料的機構帶來顯著的複雜性。某些進口材料關稅的提高迫使製造商和最終用戶重新審視供應商契約，考慮近岸外包方案，並加強達成能夠降低成本波動的長期協議。這些適應性措施對於防止臨床服務和研究活動中斷至關重要，因為即使是短期中斷也可能損害患者照護和實驗的連續性。

基於深度細分的洞察，將應用程式、產品類型、最終用戶和分銷管道連結起來，從而推動可執行的採購和服務優先排序。

深入的市場區隔揭示了不同應用領域如何驅動產品和分銷偏好。進一步的分析揭示了臨床、工業和研究領域之間微妙的相互依存關係。按應用領域分類，市場涵蓋工業測試（包括材料分析和無損檢測）、醫學影像（涵蓋PET和SPECT，包括心臟病學、神經病學和腫瘤學等PET亞專科）、製藥生產（專注於放射性示踪劑製造）以及研發（包括學術研究和製藥研究）。這些應用領域影響著對發生器和密封源產品的需求，影響著對交貨服務水準的期望，並塑造與特定應用場景相關的合規性要求。

區域分析突顯了美洲、歐洲、中東和非洲以及亞太地區在監管、物流和臨床應用模式方面的差異及其戰略意義。

區域趨勢導致了不同的管理體制、物流實際情況和臨床實施模式，進而影響鍺-68及其衍生的採購和部署方式。在美洲，先進的臨床網路和集中式卓越中心推動了對高品質產生器系統和可靠分銷服務的需求，而法規結構和國內製造能力則影響對進口和本地資源的依賴程度。美洲地區也表現出對營運效率和放射藥學服務在醫院系統中整合的強烈偏好，這影響了對發生器維護、技術支援和培訓服務的選擇。

對鍺68產業參與者的競爭格局進行分析，重點在於技術差異化、監管合規性和服務品質。

競爭格局包括製造商、發生器系統開發商、密封源製造商、專業分銷商以及專注於法規遵循、培訓和技術支援的服務供應商。市場參與企業透過投資發生器技術來提高產量可靠性，透過建立延長發生器使用壽命的機制，以及透過建立簡化監管核准和臨床實施的品質保證系統來實現差異化競爭。技術供應商與放射性藥物藥房或診斷成像網路之間的策略聯盟日益普遍，從而能夠協調部署新的示踪劑功能，並為先進的診斷實施提供風險共用模式。

為產業領導者提供切實可行的建議，以增強其供應鏈的韌性、監管應對力、客戶支援和協作創新能力

為確保業務連續性並推動成長，產業領導者應優先考慮三管齊下的策略，以平衡供應鏈韌性、合規性和以客戶為中心的服務創新。首先，加強供應商多元化策略並建立靈活的庫存管理政策，將降低關稅波動、運輸中斷和零件短缺帶來的風險，同時為臨床和研究使用者提供可預測的營運保障。其次，積極與監管機構溝通並投資於全面的合規文件，將縮短新設備的部署時間，並支持跨境分銷，從而為區域擴張和夥伴關係的建立鋪平道路。

我們採用透明的調查方法，結合關鍵相關人員訪談、監管分析和技術文獻，為我們的實用見解和操作建議提供支援。

本分析基於結構化的調查方法，該方法整合了對設備製造商、放射性藥物運營商、臨床用戶和物流供應商的訪談，並輔以對監管指南、技術標準和同行評審出版物的文獻綜述。調查方法強調定性見解和技術評估的三角驗證，以獲得反映鍺-68衍生產品在處理、分銷和臨床應用方面的實際操作情況和當前最佳實踐的見解。保密訪談提供了不同最終使用者所採用的籌資策略、維護作業和風險管理方法的背景資訊。

總之，綜合分析強調了策略合作、健全的採購體系和增強的服務對於確保鍺-68的可靠利用的重要性。

總之，鍺-68仍將是臨床影像和研究應用中的關鍵同位素，其策略重要性將受到技術進步、法規環境變化以及當前供應鏈決策的影響。 PET技術的進步、放射性藥物研發管線的不斷發展以及對供應鏈韌性的重視，凸顯了製造商、經銷商、臨床機構和研究機構之間開展合作的必要性。投資於採購多元化、嚴格合規體系和提升服務水準的相關人員，將更有能力掌握機遇，同時最大限度地降低營運風險。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依應用分類的鍺-68市場

  • 工業測試
    • 材料分析
    • 無損檢測
  • 醫學影像
    • PET影像
      • 心臟病學
      • 神經病學
      • 腫瘤學
    • SPECT影像
  • 製藥生產
  • 研究與開發
    • 學術研究
    • 藥物研究

9. 依產品類型分類的鍺 68 市場

  • 放射性藥物產生器
    • 68Ge/68Ga產生器
    • 68Ge/68mGa產生器
  • 密封輻射源
    • 可重複使用原始碼
    • 一次性醬汁

第10章 依最終用戶分類的鍺-68市場

  • 診斷中心
    • 診斷影像中心
    • PET中心
  • 醫院和診所
    • 私立醫院
    • 公立醫院
  • 製藥公司
  • 研究所
    • 政府實驗室
    • 大學

第11章 鍺68市場通路

  • 離線
  • 線上

第12章 鍺68市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 鍺68市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 鍺68 各國市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國鍺68市場

第16章：中國的鍺68市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Accelerator Applications
  • ANSTO
  • BWXT Medical Ltd.
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • Eckert & Ziegler AG
  • IRE ELiT
  • ITM Isotope Technologies Munich SE
  • JSC Karpov Institute of Physical Chemistry
  • Mallinckrodt plc
  • Nihon Medi-Physics Co., Ltd.
  • NorthStar Medical Radioisotopes LLC
  • Polatom
  • RadioMedix, Inc.
Product Code: MRR-7A380DA7C2F1

The Germanium 68 Market was valued at USD 442.61 million in 2025 and is projected to grow to USD 493.87 million in 2026, with a CAGR of 11.32%, reaching USD 937.94 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 442.61 million
Estimated Year [2026] USD 493.87 million
Forecast Year [2032] USD 937.94 million
CAGR (%) 11.32%

Comprehensive introduction to the strategic role of germanium-68 across clinical imaging, radiopharmaceutical workflows, and research infrastructures

Germanium-68 occupies a pivotal role across diagnostic imaging, radiopharmaceutical production, and research applications, serving as a parent radionuclide for gallium-68 generation and as a sealed source in calibration and testing workflows. The isotope's relevance is driven by its decay characteristics and compatibility with generator systems that enable onsite production of short-lived positron emitters, facilitating timely access to radiotracers for clinical and research settings. Given the convergence of technological advances in PET instrumentation and growing demand for targeted diagnostics, understanding the operational, regulatory, and supply-chain dimensions of germanium-68 is essential for stakeholders across healthcare, industry, and academia.

In this introduction, primary attention is placed on the isotope's functional roles and the ecosystem that supports its lifecycle, from generator manufacturing and sealed-source production to distribution and end-user handling. Key operational considerations include regulatory compliance for radioactive materials, transport logistics under stringent safety regimes, and the rise of specialized distribution channels that influence accessibility. By framing the discussion around technological utility, application breadth, and the infrastructure required for safe handling, this section establishes the analytical foundation for subsequent sections that explore shifts in landscape, tariff impacts, segmentation insights, and regional dynamics.

How innovations in imaging, localized tracer production, and supply chain modernization are reshaping access and utilization of germanium-68

The landscape for germanium-68 is undergoing transformative shifts driven by innovation in imaging modalities, evolving radiopharmaceutical pipelines, and heightened emphasis on localized supply resilience. Advances in PET imaging hardware and software have expanded the clinical utility of radiotracers derived from gallium-68, which in turn elevates demand for reliable generator systems and sealed sources. Concurrently, the emergence of modular and point-of-care radiochemistry platforms is changing how facilities approach onsite production, reducing lead times for tracer availability and enabling more flexible clinical scheduling.

Supply-chain modernization is also reshaping the market, with specialized distributors and direct-sales models competing to deliver safe, compliant, and timely shipments of radioactive materials. Regulatory harmonization efforts in certain jurisdictions aim to streamline approvals and transport, yet variations across regions continue to influence procurement strategies. Additionally, shifts in R&D priorities-particularly the proliferation of oncology, cardiology, and neurology tracers-are reinforcing the strategic importance of germanium-68 as an enabler of next-generation diagnostics. These converging dynamics compel stakeholders to reassess sourcing strategies, quality assurance protocols, and partnerships across manufacturing, logistics, and clinical operations.

Assessment of the 2025 United States tariff adjustments and their operational, procurement, and supply continuity implications for germanium-68 stakeholders

Policy measures introduced through tariff adjustments can ripple across procurement, pricing, and operational planning for radionuclide supply chains, and the United States tariff changes in 2025 have introduced notable complexity for organizations reliant on imported generator components and sealed-source materials. Increased duties on certain imported materials have prompted manufacturers and end users to revisit supplier contracts, explore nearshoring alternatives, and intensify efforts to secure long-term agreements that mitigate cost volatility. These adaptive responses are essential in maintaining uninterrupted clinical services and research activities where even short disruptions can compromise patient care and experimental continuity.

Beyond immediate procurement implications, the tariff environment has encouraged strategic rebalancing of inventory policies and contingency planning. Clinical operators and radiopharmaceutical producers are reevaluating inventory buffers, certification pathways for domestic suppliers, and collaborative models that share risk across regional partners. In parallel, manufacturers have accelerated dialogues with regulators to ensure that alternate sourcing or component substitution meets safety and performance requirements, maintaining the integrity of generator systems and sealed sources. The combined effect is a more cautious, diversified procurement approach that places premium value on supply reliability, regulatory compliance, and transparent supplier traceability.

Deep segmentation-driven insights connecting applications, product types, end users, and distribution channels to practical procurement and service priorities

Insightful segmentation illuminates how distinct application areas drive product and distribution preferences, and a closer look reveals nuanced interdependencies across clinical, industrial, and research domains. Based on application, the market spans industrial testing including material analysis and non-destructive testing, medical imaging covering PET and SPECT with PET sub-specializations in cardiology, neurology, and oncology, pharmaceutical production focused on radiotracer manufacturing, and research and development including academic and pharmaceutical research. These application domains affect demand for generator versus sealed-source products, influence service-level expectations for delivery, and shape compliance needs tied to specific use cases.

Based on product type, differentiation between radiopharmaceutical generators-further segmented into 68Ge/68Ga generators and 68Ge/68mGa generators-and sealed sources categorized as reusable or single-use informs lifecycle management and total cost of ownership considerations. Generator-based workflows favor facilities with robust radiochemistry capabilities, while sealed sources are often preferred in calibration and industrial test scenarios where repeatable activity profiles are required. Based on end user, diagnostic centers including imaging and PET centers, hospitals and clinics across private and public sectors, pharmaceutical manufacturers focused on radiopharmaceutical production, and research institutes such as government labs and universities each have distinct procurement priorities, regulatory obligations, and technical support needs. Finally, distribution channel dynamics-direct sales, distributors including general and specialized distributors, and online channels-determine availability, lead times, and the level of technical service provided during and after delivery. Collectively, these segmentation lenses guide product development, service design, and commercial strategies to better align supply with the operational realities of each customer cohort.

Regional analysis highlighting distinct regulatory, logistical, and clinical adoption patterns across Americas, EMEA, and Asia-Pacific and their strategic implications

Regional dynamics introduce distinct regulatory regimes, logistical realities, and clinical adoption patterns that shape how organizations source and deploy germanium-68 and derivative products. In the Americas, advanced clinical networks and concentrated centers of excellence drive demand for high-quality generator systems and robust distribution services, while regulatory frameworks and domestic manufacturing capacities influence reliance on imports versus locally produced sources. The Americas also exhibit a strong orientation toward operational efficiency and integration of radiopharmacy services within hospital systems, which affects preferences for generator maintenance, technical support, and training offerings.

Across Europe, the Middle East, and Africa, heterogeneous regulatory environments and uneven infrastructure development create a mosaic of access levels; some markets demonstrate sophisticated nuclear medicine capabilities with established radiopharmaceutical ecosystems, whereas others prioritize incremental capacity building and partnerships to enable clinical adoption. In Asia-Pacific, rapid expansion of nuclear medicine services, growing investment in healthcare infrastructure, and strong research activity fuel diverse demand across both clinical imaging and radiotracer production. Logistics complexities, transport safety rules, and regional regulatory nuances remain important considerations in all territories, influencing distribution strategies, localization opportunities, and collaborative models between suppliers and regional stakeholders.

Competitive landscape analysis focusing on technological differentiation, regulatory adherence, and service excellence among germanium-68 industry participants

The competitive environment features manufacturers, generator system developers, sealed-source producers, specialized distributors, and service providers focused on regulatory compliance, training, and technical support. Market participants differentiate through investments in generator technology that enhance yield reliability, mechanisms that extend usable lifetimes of generators, and quality-assurance systems that simplify regulatory approvals and clinical adoption. Strategic partnerships between technology providers and radiopharmacies or imaging networks are increasingly common, enabling coordinated rollouts of new tracer capabilities and shared risk models for adoption of advanced diagnostics.

A critical axis of differentiation lies in after-sale support, including installation, preventive maintenance, and training for safe handling of radioactive materials. Companies that provide transparent supply-chain traceability, responsive logistics solutions, and robust documentation to satisfy regulatory inspections tend to build stronger trust with hospitals, diagnostic centers, and research institutes. Moreover, players that engage in collaborative research with academic centers or pharmaceutical firms contribute to innovation pipelines, reinforcing their reputational positioning and opening avenues for co-development of new generator chemistries or sealed-source applications.

Actionable recommendations for industry leaders to strengthen resilience, regulatory readiness, customer support, and collaborative innovation across the supply chain

Industry leaders should prioritize a three-pronged approach that balances supply resilience, regulatory alignment, and customer-centric service innovations to safeguard continuity and foster growth. First, strengthening supplier diversification strategies and establishing flexible inventory policies will mitigate exposure to tariff fluctuations, transport disruptions, and component shortages, while enabling more predictable operations for clinical and research users. Second, proactive engagement with regulatory bodies and investment in comprehensive compliance documentation will reduce time-to-deployment for new installations and support cross-border distribution, easing the path for regional expansion and partnerships.

Third, enhancing after-sales support, including targeted training programs for end users, modular maintenance contracts, and remote diagnostics, will increase equipment uptime and customer satisfaction. Leaders should also cultivate collaborative research agreements with academic and pharmaceutical organizations to co-develop next-generation generator systems and radiotracer production methodologies. Finally, incorporating digital tools-such as inventory tracking, shipment monitoring, and online ordering portals-can improve transparency, shorten procurement cycles, and provide analytics that inform capacity planning and product development decisions.

Transparent research methodology combining primary stakeholder interviews, regulatory analysis, and technical literature to underpin actionable insights and operational recommendations

This analysis is built on a structured research approach that integrates primary interviews with equipment manufacturers, radiopharmacy operators, clinical users, and logistics providers, complemented by secondary literature review of regulatory guidance, technical standards, and peer-reviewed publications. The methodology emphasizes triangulation of qualitative insights and technical assessments to ensure findings reflect operational realities and prevailing best practices in handling, distribution, and clinical use of germanium-68 derived products. Confidential interviews provided context on procurement strategies, maintenance practices, and risk management approaches adopted by varied end users.

Data synthesis prioritized cross-validation between practitioner perspectives and documented regulatory frameworks to present balanced conclusions. Case examples drawn from hospital radiopharmacies, industrial testing labs, and research institutes illustrate practical considerations for generator deployment and sealed-source utilization. Limitations include variability in regional regulatory interpretations and the evolving nature of tariff and trade policy, which can alter procurement landscapes; therefore, recommendations remain centered on operational resilience, compliance rigor, and adaptive commercial models that accommodate changing external conditions.

Concluding synthesis emphasizing strategic collaborations, resilient procurement, and service enhancements to secure reliable access to germanium-68 capabilities

In conclusion, germanium-68 continues to be a cornerstone isotope for clinical imaging and research applications, and its strategic importance will be shaped by technological advances, regulatory dynamics, and supply-chain decisions made today. The confluence of improved PET capabilities, evolving radiopharmaceutical pipelines, and a focus on supply resilience highlights the need for coordinated strategies across manufacturers, distributors, clinical operators, and research institutions. Stakeholders that invest in diversified sourcing, rigorous compliance systems, and enhanced service offerings are better positioned to capitalize on opportunities while minimizing operational risk.

Looking ahead, collaboration between industry and clinical research will be crucial to translate generator and sealed-source innovations into routine clinical practice. By adopting adaptive procurement strategies, strengthening technical support frameworks, and engaging proactively with regulators, organizations can ensure continuity of care and accelerate the responsible adoption of next-generation diagnostic tools. The insights in this executive summary are intended to inform strategic decisions, guide operational improvements, and catalyze partnerships that sustain high-quality access to germanium-68 derived capabilities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Germanium 68 Market, by Application

  • 8.1. Industrial Testing
    • 8.1.1. Material Analysis
    • 8.1.2. Non-Destructive Testing
  • 8.2. Medical Imaging
    • 8.2.1. PET Imaging
      • 8.2.1.1. Cardiology
      • 8.2.1.2. Neurology
      • 8.2.1.3. Oncology
    • 8.2.2. SPECT Imaging
  • 8.3. Pharmaceutical Production
  • 8.4. Research & Development
    • 8.4.1. Academic Research
    • 8.4.2. Pharmaceutical Research

9. Germanium 68 Market, by Product Type

  • 9.1. Radiopharmaceutical Generator
    • 9.1.1. 68Ge/68Ga Generators
    • 9.1.2. 68Ge/68mGa Generators
  • 9.2. Sealed Source
    • 9.2.1. Reusable Source
    • 9.2.2. Single Use Source

10. Germanium 68 Market, by End User

  • 10.1. Diagnostic Centers
    • 10.1.1. Imaging Centers
    • 10.1.2. PET Centers
  • 10.2. Hospitals & Clinics
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Institutes
    • 10.4.1. Government Labs
    • 10.4.2. Universities

11. Germanium 68 Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Germanium 68 Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Germanium 68 Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Germanium 68 Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Germanium 68 Market

16. China Germanium 68 Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Accelerator Applications
  • 17.6. ANSTO
  • 17.7. BWXT Medical Ltd.
  • 17.8. China Isotope & Radiation Corporation
  • 17.9. Curium Pharma
  • 17.10. Eckert & Ziegler AG
  • 17.11. IRE ELiT
  • 17.12. ITM Isotope Technologies Munich SE
  • 17.13. JSC Karpov Institute of Physical Chemistry
  • 17.14. Mallinckrodt plc
  • 17.15. Nihon Medi-Physics Co., Ltd.
  • 17.16. NorthStar Medical Radioisotopes LLC
  • 17.17. Polatom
  • 17.18. RadioMedix, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GERMANIUM 68 MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GERMANIUM 68 MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GERMANIUM 68 MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GERMANIUM 68 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GERMANIUM 68 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GERMANIUM 68 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS GERMANIUM 68 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL GERMANIUM 68 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. GCC GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. GCC GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. GCC GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 240. GCC GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 241. GCC GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. GCC GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 244. GCC GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GCC GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. G7 GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. G7 GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 281. G7 GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 282. G7 GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 283. G7 GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. G7 GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 286. G7 GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 287. G7 GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. G7 GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. NATO GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. NATO GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. NATO GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. NATO GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 297. NATO GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 298. NATO GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 300. NATO GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 305. NATO GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)